MHRA offers to support ‘orphaned’ manufacturers

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has put in place a process to support UK manufacturers affected by LRQA’s decision to close its medical device business.

Subject to some conditions, MHRA is able to support LRQA manufacturers in their transition to a new notified body by allowing products to continue to be able to be placed on the EU market. LRQA clients should have received communication from the MHRA; if not, or if there are any other questions, they should contact devices.support@mhra.gov.uk